Three Outbreak-causingNeisseria meningitidis SerogroupC Clones, Brazil1-Reference-Cited by-同舟云学术

Three Outbreak-causingNeisseria meningitidis SerogroupC Clones, Brazil1

Published:2013-11 Issue:11 Volume:19 Page:
ISSN:1080-6040
Container-title:Emerging Infectious Diseases
language:
Short-container-title:Emerg. Infect. Dis.

Author:

Barroso David E.,Castiñeiras Terezinha M.P.P.,Freitas Fernanda S.,Marsh Jane W.,Krauland Mary G.,Tulenko Mary M.,Fonseca Érica L.,Vicente Ana C.P.,Rebelo Maria C.,Cerqueira Elaine O.,Xavier Adriano C.,Cardozo Ana P.C.M.,da Silva Simone E.M.,Harrison Lee H.

Publisher

Centers for Disease Control and Prevention (CDC)

Subject

Infectious Diseases,Microbiology (medical),Epidemiology

Reference10 articles.

1. Microbiological epidemiological history of meningococcal disease in Rio de Janeiro, Brazil.;Barroso;Braz J Infect Dis,2010

2. Assessment of a two-step nucleic acid amplification assay for detection of Neisseria meningitidis followed by capsular genogrouping.;Rebelo;Mem Inst Oswaldo Cruz,2006

3. Capsular switching in invasive Neisseria meningitidis, Brazil.;Castiñeiras;Emerg Infect Dis,2012

4. Risk of meningococcal infection in college students.;Harrison;JAMA,1999

5. Clusters of meningococcal disease in school and preschool settings in England and Wales: what is the risk?;Davison;Arch Dis Child,2004

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meningococcal disease epidemiology in Brazil (2005–2018) and impact of MenC vaccination;Vaccine;2021-01

2. Epidemiological burden of meningococcal disease in Latin America: A systematic literature review;International Journal of Infectious Diseases;2019-08

3. Whole genome sequencing for investigations of meningococcal outbreaks in the United States: a retrospective analysis;Scientific Reports;2018-10-25

4. Neisseria meningitidis disease-associated clones in Amazonas State, Brazil;Infectious Diseases;2018-04-06

5. Immunogenicity and safety of concomitant administration of meningococcal serogroup B (4CMenB) and serogroup C (MenC-CRM) vaccines in infants: A phase 3b, randomized controlled trial;Vaccine;2017-04